Navigation Links
Ferring to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
Date:2/12/2013

SAN FRANCISCO, Feb. 12, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present pivotal Phase 3 efficacy and safety data from its EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 33rd annual meeting of the Society for Maternal-Fetal Medicine (SMFM) in San Francisco, February 11 - 16. These and other research findings formed the basis for Ferring's New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) supporting the use of the controlled release MVI as a treatment option for cervical ripening as part of the labor induction process.

Studies accepted for presentation include

  • An oral presentation on Sat., Feb. 16 (9 a.m. – 9:15 a.m. PST), titled "Efficacy and safety of misoprostol vaginal insert compared with dinoprostone vaginal insert for labor induction" (lead author: Deborah A. Wing , MD, University of California, Irvine); and
  • A poster presentation on Thurs., Feb. 14 (3:30 p.m. – 5:30 p.m. PST), titled "Comparison of misoprostol vaginal insert and dinoprostone vaginal insert: incidence of treatment-emergent adverse events" (lead author: Stacey Ehrenberg-Buchner , MD, University of Michigan Health System).

*The EXPEDITE Study: A Phase 3, double blind, randomized, multicenter study of exogenous prostaglandin comparing the efficacy and safety of the misoprostol vaginal insert (MVI) 200 mcg to the dinoprostone vaginal insert for reducing time to vaginal delivery in pregnant women at term.

For further information, contact:
Leila Boukassi
MSL New York
leila.boukassi@mslgroup.com; 646.500.7735 

About Ferring Pharmaceuticals:
Ferring Pharmaceuticals is a research-driven speciality b
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
2. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
3. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
4. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
5. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
6. Isis Reports Financial Results and Highlights for First Quarter 2012
7. Delcath Highlights First Quarter 2012 And Recent Accomplishments
8. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
9. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
10. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
11. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Incision Closures - Global Strategic Business Report" report to ... for the US, Canada , ... Asia-Pacific , Latin America , and ... markets for Surgical Incision Closures in US$ Million by the ...
(Date:6/2/2015)... 2, 2015  Only a quarter of physicians who ... patients they prescribe them to, according to new survey ... Medicine (BUSM) and myCME , Haymarket Medical ... Alford, M.D. , director of BUSM,s Safe and ... said, "This indicates a critical need for provider education ...
(Date:6/2/2015)... June 2, 2015  ErgoNurse, the leader in bedside safety ... products in the United States , have ... long-term care and skilled nursing markets. ... Thousands of ... fully take advantage of the ErgoNurse products to stop unnecessarily ...
Breaking Medicine Technology:Surgical Incision Closures - Global Strategic Business Report 2015 2Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2
... July 22, and OSAKA, Japan, July 23 ... Takeda Global Research & Development Center, Inc., a wholly ... U.S. Food and Drug Administration (FDA) that the FDA ... for the fixed-dose combination (FDC) of alogliptin and ACTOS((R)) ...
... , MENLO PARK, Calif., July 22 Apieron, ... positive coverage policy for the measurement of exhaled nitric oxide ... peer-reviewed evidence is sufficient to support benefit coverage for the ... the measurement of exhaled nitric oxide is considered medically necessary ...
Cached Medicine Technology:Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 2Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 3CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment 2
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 Food ... hosting its sixth annual “Thriller on the Griller” events, ... Carolina and South Carolina locations. Each event will raise ... dedicated to restoring a sense of self, restoring the ... and our military families. , Through these events, ...
(Date:6/2/2015)... June 02, 2015 Highly qualified dental care ... plan to drive prolific change in the dental tourism industry ... Team Dental Clinic offers a full range of superior ... structure for dental tourism. , Partnered with a top ... committed to advancing dentistry and has earned a reputation as ...
(Date:6/2/2015)... The term “Augmented Reality” was coined in ... the real world. Since then many promising technologies have ... map of the vasculature on the surface of the ... AccuVein, the leader in vein visualization, exemplifies this growth ... such widespread adoption of its AccuVein AV400 devices that ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... a person. , According to Psychology Today, humans are a ... explain that curiosity is a part of human development. People ...
(Date:6/2/2015)... FL (PRWEB) June 02, 2015 MedPro ... staffing services to healthcare facilities, today announced the worldwide ... and effective mobile tool to help candidates find best ... Glassdoor survey released in 2014, 9 in 10 job ... during their job search. , The MedPro Top Jobs ...
Breaking Medicine News(10 mins):Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2
... French study in rats finds olanzapine changes metabolism in ... of the antipsychotic medication olanzapine may put a person ... 2 diabetes, new findings show. , A team of ... found that, after consuming olanzapine over several weeks, the ...
... the Country Gather to Discuss, Interactive Patient Care Topics and ... ... Patient Experience, WASHINGTON, April 7, 2008 ... today,announced the kick-off of GetConnected2008. Designed exclusively for the,GetWellNetwork community, ...
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), ... live webcast at 8:30 am (EDT) on Thursday, April ... discuss the Company,s April 7, 2008,meeting with The US ... for the Company,s novel once-a-day oral antibiotic, cethromycin,as a ...
... is caused by mutations that allow defective blood ... effective therapies it is crucial to know which mutations ... leukaemic cells. Researchers from the European Molecular Biology Laboratory ... the Universities of Harvard, USA, and Lund, Sweden, have ...
... N.Y., April 7, 2008 CardWorks Servicing, LLC,("CardWorks") ... known as Cardholder Management Services, LLC ("CMS"), announced,today ... the new HumanaAdvance,Visa Card. CardWorks will partner with ... offer the HumanaAdvance Visa. Humana,is one of the ...
... treatment aren,t known, researchers say , , MONDAY, April 7 ... bone density and reduce bone loss in older men ... prevent osteoporosis, a new study suggests. , Testosterone ... muscle mass in some men. However, the hormone treatment ...
Cached Medicine News:Health News:Antipsychotic Drug Boosts Risk of Heart Disease, Diabetes 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 3Health News:Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA 2Health News:Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA 3Health News:An unexpected way to cause leukemia 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 3Health News:Testosterone Therapy May Reduce Bone Loss in Older Men 2
Angled for temporal approach. Solid 14 mm blades. Dull finish....
Open 11 mm blades. Polished finish....
Open 10 mm blades. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Medicine Products: